Objectıves: Atherosclerotic renal artery stenosis (ARAS) is associated with uncontrolled hypertension and chronic renal failure. The aim of this study is to evaluate the influence of gender and presence of chronic renal failure on the outcomes of percutaneous transluminal renal artery stenting (PTRAS) due atherosclerosis. Methods: A total of 28 ARAS patients underwent PTRAS and 36 stents were placed. Basal characteristics, laboratory data and blood pressure of patients were recorded. The differences between genders and improvement/deterioration of renal functions and blood pressure were analyzed. The predictors of outcomes were determined. Results: Baseline characteristics were similar between men and women. Significant improvement of systolic and diastolic blood pressure control was achieved after PTRAS (153.04AE17.07 mmHg vs. 124.75AE11.40 mmHg, p¼0.001 and 92.50AE10.76 mmHg vs. 77.54AE8.23 mmHg, p<0.001, respectively) ( Table-1 ). Although mean estimated glomerular filtration rate (eGFR) and creatinine levels did not significantly improved at 6 month follow up visit in compared to baseline values, of the 28 patients 13 (46.4%) patients had improvement of renal functions. Conclusıon: Our results suggests that PTRAS is a safe procedure and may offer blood pressure control but beneficial effects of PTRAS on renal function may be anticipated in selected group of patients, especially those with a low eGFR.
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Comparison of Carvedilol, Nebivolol and Metoprolol for the Prevention of Contrast Induced Nephropathy Ça gdaş Akgüllü, Ufuk Eryılmaz, Ahmet Huyut, Tolga Hekim, Hasan Güngör, Cemil Zencir Adnan Menderes University Faculty of Medicine, Department of Cardiology, Aydin Background: Metoprolol, carvedilol and nebivolol were different beta blockers with different properties. In the literature there are various studies evaluating renal effects of these beta blockers under different conditions. However, to the best of our knowledge there is not any study comparing preventive effects of these three beta blockers with each other against contrast induced nephropathy (CIN). Aım: We aimed to investigate and compare the probable prophylactic effects of three beta blocker agents, carvedilol, nebivalol and metoprolol against CIN. Method: 184 patients who were hospitalized for further evaluation with coronary angiography and have been using beta blocker agent (50 mg metoprolol, 25 mg carvedilol or 5 mg nebivolol) at least for a week were enrolled to the study. Exclusion criteria included dialysis patients, recent exposure to contrastmedia or a nephrotoxic agent within 7 days before the study, urgent percutaneous coronary intervention (PCI), requiring loop diuretics, theophylline/ aminophylline, dopamine throughout the study, hemodynamically unstable patients. Patients were divided into three groups: metoprolol (M) (64 patient), nebivolol (N) (60 patient), carvedilol (C) (60 patient). All groups were hydrated before and after the coronary procedure for 12 hours with the rate of 1 ml/kg/hour intravenous isotonic saline. Serum cretainine (Cr) levels were checked in the second and fifth days of the study. The primary end point was the occurence of CIN. We defined CIN as an increase !0.5 mg/dL and/or !25% in serum creatinine (SCr) concentration at day 2 and/or day 5 of the procedure. Results: The distribution of various characteristics of the participants is shown in Table 1and Table 2 . Seven (10.9%) patients in group M developed CIN, as did 5 patients (8.3%) in group N and 2 patients (3.3%) in group C. Patients in carvedilol group developed less CIN, however the difference with the group C and the others did not reach statistical significance (p¼0.283) ( Figure 1 ). Changes in mean Cr level from baseline to day 2 and day 5 were not statistically significant in all groups. Conclusıon: If there is indication for a beta blocker therapy before the coronary angiography procedure, although the comperative results with metoprolol and nebivolol did not reach statistical significance, this study demonstrated a weak evidence favouring against carvedilol prescription as it would be a better choice for the prevention of CIN. Objectıves: Our goal is to evaluate the effectiveness, reliability, advantages and the results of early-to-mid-term of percutaneous treatment of lower extremity strictures. Background: Technological advances in the past decade have shifted revascularization strategies from traditional open surgical approaches toward lower-morbidity percutaneous endovascular treatments for patients with lower extremity peripheral arterial disease (PAD). The role of endovascular interventions is also expanding in the treatment of limb-threatening ischemia. Especially in chronic limb ischemia and foot ulcers, diabetic patients with inoperable, there is growing interest below the knee interventions.
Methods: Between May 2011 and May 2013, 85 patients with stenosis of the lower limb arteries (iliac-femoral-popliteal-below the knee) and treated percutaneously, enrolled in the study. Although medical therapy, patients with intermittent claudication and have >70% stenosis in iliac or femoral artery, stenting procedure was performed after primary stenting or balloon angioplasty. Symptomatic patients with >70% stenosis of popliteal or below-knee artery, balloon angioplasty was performed. After the patients were followed up clinically. Results: Tecnical success was achieved in 84 patients (98,8%). Predilatation before stent placement, 33,3% of cases performed. Post dilation procedure was performed in 66,6% of patients with used the self-expanding stent. 84 patients with iliac-femoral artery stenosis, stenting procedure is applied and concomitantly 6 patients with popliteal artery and distal to the stenosis, the balloon angioplasty was performed. Average follow-up time was 10,0AE6,3 months.
(1 -25 Months). Including death, myocardial infarction, major bleeding complications were not observed depending on percutaneous procedures. Iliac stent in a patient as a complication inferior vena cava fistula formation, this complication was treated using a stent-graft. 7 patients with diabetes and foot wounds that never heal, healed wounds were observed during follow-up after the procedure. In the clinical follow-up, claudication complaints decreased and increased walking distances observed. Conclusıon: Technical success rate and early-midterm outcomes of percutaneous treatment for PAD are magnificent. We believe that percutaneous treatment methods in lower extremity arterial stenosis, will be more widespread with percutaneous treatment techniques and operator experience increases.
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Percutaneous Results: The mean ductus waist diameter measured by angiographic examination was 5AE2 mm (2-9 mm). Procedure was successfully performed in all patients. Occluder device embolization was occurred in one patient in whom device was retrieved by snare catheter and PDA was successfully closed with same device. The early total occlusion rate was 85%. Occlusion rate as determined by echocardiographic control performed the day after was 95% whereas 100% at first month. In the follow-up of 19AE9 months, no complications were observed. Conclusıon: Percutaneous closure of PDA using ADO I and II devices are safe and effective.
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Comparison Purpose: Atherosclerosis is associated with the hemodynamic factors emerged from the geometry of vessels outside of the traditional risk factors. When compared C and S (sigma) shape of right coronary artery (RCA), C shape was found to be more associated with coronary artery disease in previous studies. However, in patients admitted with acute myocardial infarction(AMI) from the RCA, the effect of these two geometric shape of RCA did not evaluated on TIMI frame count (TFC), distribution and length of the lesion. The aim this study was to compare intracoronary flow rates, localization and severity of lesion between C and S shapes of RCA on coronary angiography images by evaluation of angiographic images of primary percutaneous interventions in AMI which is caused by RCA in our center. Methods: The angiographic images of 163 of patients were evaluated who performed primary percutaneous intervention due to AMI from RCA. Patients were divided into two groups according to the geometric shape of RCA. Clinical and angiographic parameters were compared in terms of C and S shapes of RCA. 
